Recent News

• 06.06.2025 - Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
• 06.05.2025 - Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
• 05.22.2025 - Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
• 05.07.2025 - PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement
• 04.23.2025 - United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
• 04.17.2025 - United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
• 04.16.2025 - Biomerica Announces Reverse Stock Split
• 04.15.2025 - Biomerica Reports Third Quarter Fiscal 2025 Financial Results
• 02.26.2025 - Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
• 02.19.2025 - Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Recent Filings

• 06.06.2025 - 8-K Current report
• 06.06.2025 - 3 Initial statement of beneficial ownership of securities
• 06.06.2025 - EX-99.1 EX-99.1
• 04.16.2025 - 8-K Current report
• 04.16.2025 - EX-99.1 EX-99.1
• 04.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.11.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors